Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis (vol 344, pg 382, 2001)

被引：0
|
作者：
Karassa, FB
Isenberg, DA
机构：
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2001年 / 344卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1176 / 1176
页数：1
相关论文
共 50 条
  • [31] The efficacy of low-dose mycophenolate mofetil for treatment of lupus nephritis in Taiwanese patients with systemic lupus erythematosus
    Weng, Meng-Yu
    Weng, Chia-Tse
    Liu, Ming-Fei
    [J]. CLINICAL RHEUMATOLOGY, 2010, 29 (07) : 771 - 775
  • [32] Efficacy of long-term maintenance therapy with mycophenolate mofetil in lupus nephritis
    Rezaieyazdi, Zahra
    Tavakoli, Tahmine
    Khajehdaluee, Mohammad
    Honarmand, Shahram
    [J]. SPRINGERPLUS, 2014, 3
  • [33] Surveillance for the use of mycophenolate mofetil for adult patients with lupus nephritis in Japan
    Yasuda, Shinsuke
    Atsumi, Tatsuya
    Shimamura, Sanae
    Ono, Kota
    Hiromura, Keiju
    Sada, Kenei
    Mori, Masaaki
    Takei, Syuji
    Kawaguchi, Yasushi
    Tamura, Naoto
    Takasaki, Yoshinari
    [J]. MODERN RHEUMATOLOGY, 2015, 25 (06) : 854 - 857
  • [34] Efficacy and safety of high-dose of mycophenolate mofetil compared with cyclophosphamide pulse therapy as induction therapy in Japanese patients with proliferative lupus nephritis
    Ohkubo, Naoaki
    Iwata, Shigeru
    Nakano, Kazuhisa
    Miyagawa, Ippei
    Hanami, Kentaro
    Fukuyo, Shunsuke
    Miyazaki, Yusuke
    Kawabe, Akio
    Nakayamada, Shingo
    Tanaka, Yoshiya
    [J]. MODERN RHEUMATOLOGY, 2022, 32 (06) : 1077 - 1085
  • [35] Rituximab and mycophenolate mofetil for relapsing proliferative lupus nephritis: a long-term prospective study
    Boletis, John N.
    Marinaki, Smaragde
    Skalioti, Chryssanthe
    Lionaki, Sofia S.
    Iniotaki, Aliki
    Sfikakis, Petros P.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (07) : 2157 - 2160
  • [36] Longterm Followup After Tapering Mycophenolate Mofetil During Maintenance Treatment for Proliferative Lupus Nephritis
    Laskari, Katerina
    Tzioufas, Athanasios G.
    Antoniou, Anna
    Moutsopoulos, Haralampos M.
    [J]. JOURNAL OF RHEUMATOLOGY, 2011, 38 (07) : 1304 - 1308
  • [37] Pharmacokinetics of Concentration-Controlled Mycophenolate Mofetil in Proliferative Lupus Nephritis: An Observational Cohort Study
    Alexander, Suceena
    Fleming, Denise H.
    Mathew, Binu S.
    Varughese, Santosh
    Jeyaseelan, Visalakshi
    Tamilarasi, Veerasamy
    Jacob, Chakko K.
    John, George T.
    [J]. THERAPEUTIC DRUG MONITORING, 2014, 36 (04) : 423 - 432
  • [38] Efficacy and safety of mycophenolate mofetil and tacrolimus combination therapy in patients with lupus nephritis: a nationwide multicentre study
    Park, D-J
    Kang, J-H
    Lee, K-E
    Bae, S-C
    Chung, W-T
    Choe, J-Y
    Jung, S-Y
    Kim, Y-S
    Lee, H-S
    Lee, J.
    Lee, Y-A
    Park, S-H
    Park, Y-J
    Suh, C-H
    Yoo, D-H
    Lee, S-S
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 37 (01) : 89 - 96
  • [39] Efficacy of mycophenolate mofetil in Japanese patients with systemic lupus erythematosus
    Mai Kawazoe
    Kaichi Kaneko
    Zento Yamada
    Shotaro Masuoka
    Satoshi Mizutani
    Soichi Yamada
    Kotaro Shikano
    Hiroshi Sato
    Makoto Kaburaki
    Sei Muraoka
    Shinichi Kawai
    Toshihiro Nanki
    [J]. Clinical Rheumatology, 2019, 38 : 1571 - 1578
  • [40] Efficacy of mycophenolate mofetil in Japanese patients with systemic lupus erythematosus
    Kawazoe, Mai
    Kaneko, Kaichi
    Yamada, Zento
    Masuoka, Shotaro
    Mizutani, Satoshi
    Yamada, Soichi
    Shikano, Kotaro
    Sato, Hiroshi
    Kaburaki, Makoto
    Muraoka, Sei
    Kawai, Shinichi
    Nanki, Toshihiro
    [J]. CLINICAL RHEUMATOLOGY, 2019, 38 (06) : 1571 - 1578
12345